BIO-TECHNE Corp (TECH) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — TECH

Balance Sheet

(in billions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	0.21	0.17	0.14	0.14	0.18	0.19	0.14	0.13	0.15	0.13	0.16	0.17	0.16	0.21	0.20	0.19	0.17	0.17
Short-term Investments	--	--	--	0.00	0.00	0.00	0.01	0.01	0.02	0.03	0.03	0.04	--	--	--	--	--	--
Accounts Receivable	0.21	0.18	0.18	0.24	0.22	0.22	0.23	0.21	0.20	0.22	0.18	0.17	0.20	0.15	0.15	0.16	0.13	0.12
Inventory	0.20	0.21	0.20	0.19	0.19	0.19	0.18	0.18	0.19	0.17	0.16	0.15	0.13	0.12	0.12	0.11	0.11	0.11
Total Current Assets	0.69	0.64	0.61	0.63	0.63	0.65	0.61	0.59	0.59	0.57	0.57	0.55	0.59	0.59	0.54	0.57	0.54	0.54
Property, Plant & Equipment	0.23	0.23	0.24	0.25	0.25	0.25	0.24	0.23	0.23	0.22	0.22	0.22	0.22	0.21	0.21	0.20	0.20	0.19
Goodwill	0.98	0.98	0.98	0.97	0.96	0.98	0.97	0.98	0.97	0.87	0.87	0.87	0.83	0.83	0.84	0.75	0.75	0.73
Intangible Assets	0.32	0.33	0.35	0.44	0.46	0.49	0.50	0.53	0.56	0.53	0.54	0.56	0.53	0.55	0.57	0.49	0.50	0.51
Total Non-current Assets*	1.86	1.89	1.92	2.02	2.04	2.09	2.11	2.14	2.16	2.03	1.80	1.80	1.71	1.71	1.73	1.52	1.53	1.51
Total Assets	2.55	2.52	2.53	2.64	2.67	2.74	2.72	2.73	2.76	2.60	2.36	2.35	2.30	2.30	2.27	2.08	2.07	2.05
Accounts Payable	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.03	0.03	0.03	0.03	0.03	0.02	0.03
Total Current Liabilities	0.15	0.14	0.14	0.17	0.16	0.14	0.15	0.14	0.13	0.14	0.13	0.14	0.17	0.15	0.13	0.14	0.12	0.11
Long-term Debt	0.20	0.26	0.30	0.33	0.30	0.30	0.39	0.45	0.44	0.37	0.20	0.26	0.25	0.27	0.29	0.20	0.22	0.31
Total Non-current Liabilities*	0.31	0.37	--	0.46	0.43	0.46	0.56	0.63	0.63	0.57	0.41	0.46	0.42	0.45	0.50	0.41	0.43	0.51
Total Liabilities*	0.47	0.51	--	0.63	0.59	0.60	0.71	0.77	0.76	0.71	0.54	0.60	0.59	0.60	0.63	0.55	0.55	0.61
Retained Earnings	1.15	1.11	1.08	1.20	1.29	1.34	1.30	1.26	1.33	1.25	1.20	1.16	1.13	1.15	1.12	1.09	1.10	1.07
Total Stockholder Equity	2.09	2.01	--	2.02	2.08	2.14	2.01	1.96	2.00	1.89	1.83	1.75	1.71	1.70	1.64	1.54	1.52	1.44

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Total Revenue	321.19	311.42	295.88	286.56	316.96	316.18	297.03	289.46	306.10	303.43	272.60	276.94	301.32	294.15	271.58	269.65	288.23	290.38	269.28	257.72
Cost of Revenue	109.80	103.13	104.60	98.44	118.15	101.63	103.15	106.44	102.75	98.83	96.01	91.74	96.62	91.98	88.22	90.06	87.88	88.92	85.59	86.72
Gross Profit	211.39	208.29	191.28	188.11	198.81	214.56	193.89	183.02	203.35	204.60	176.59	185.19	204.70	202.16	183.36	179.60	200.35	201.46	183.69	171.00
Selling, General & Admin	113.17	109.34	113.69	116.21	196.64	151.27	121.45	119.16	133.54	111.84	115.67	105.33	86.76	99.24	93.01	99.38	96.63	89.27	100.69	86.18
Total Operating Expenses	137.12	132.79	136.82	140.45	222.67	175.85	146.47	143.03	157.53	137.60	138.58	129.33	110.17	121.95	115.47	123.28	119.78	111.01	121.34	107.78
Operating Income	74.28	75.50	54.46	47.66	(23.86)	38.71	47.42	39.99	45.82	67.00	38.00	55.86	94.53	80.21	67.89	56.32	80.57	90.45	62.35	63.22
Interest Expense	--	--	--	--	--	--	--	--	--	4.01	4.33	4.89	3.70	1.37	2.36	3.79	2.51	2.49	2.90	3.41
Pretax Income	70.68	71.22	50.78	47.99	(22.86)	38.27	42.88	40.17	41.66	61.08	33.39	49.56	88.32	80.20	66.43	103.72	79.05	68.77	86.18	67.38
Tax Provision	16.06	20.18	12.78	9.81	(5.18)	15.69	7.99	6.57	1.07	12.03	5.92	(1.43)	12.83	9.98	16.42	13.98	17.14	8.63	14.12	(1.60)
Net Income	54.62	51.05	38.01	38.19	(17.68)	22.59	34.89	33.60	40.59	49.06	27.47	50.99	75.49	70.22	50.01	89.56	61.52	60.74	80.17	69.61
Basic EPS	--	0.33	0.24	0.25	(0.10)	0.14	0.22	0.21	0.27	0.31	0.17	0.32	(1.24)	0.45	0.32	2.28	1.56	1.55	2.04	1.78
Diluted EPS	--	0.32	0.24	0.24	(0.11)	0.14	0.22	0.21	0.26	0.31	0.17	0.31	(1.19)	0.43	0.31	2.21	1.52	1.48	1.94	1.69

Cash Flow Statement

(in millions USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Operating Cash Flow	95.42	86.66	82.41	27.59	98.20	41.12	84.35	63.89	75.50	80.99	83.12	59.38	83.39	50.54	64.38	56.08	102.72	73.13	100.99	48.43
Capital Expenditures	8.48	9.09	5.92	5.36	4.89	10.12	6.82	9.17	17.98	16.44	14.86	13.59	10.83	11.75	6.11	9.56	13.57	15.10	10.17	6.07
Free Cash Flow*	86.94	77.58	76.49	22.22	93.31	31.00	77.53	54.72	57.52	64.55	68.25	45.79	72.56	38.79	58.28	46.53	89.15	58.03	90.83	42.36
Investing Cash Flow	(7.06)	(5.82)	(5.92)	0.61	0.41	(8.87)	(5.03)	(21.68)	(8.81)	(16.44)	(23.67)	(154.11)	(4.76)	(241.10)	(0.11)	(19.69)	(18.57)	(35.99)	(35.17)	(7.12)
Financing Cash Flow	(33.21)	(42.72)	(48.99)	(44.20)	(90.45)	(68.04)	(83.84)	(11.57)	(60.09)	(52.42)	(81.40)	71.51	(24.22)	150.84	(72.19)	(31.81)	(65.73)	(84.06)	(53.38)	(39.68)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Dividends Per Share	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	(0.16)	0.08	0.08	0.32	0.32	0.32	0.32	0.32